본문으로 건너뛰기
← 뒤로

Association of miR-338-3p with survival outcomes in gastric cancer patients who received peri-operative blood transfusion.

1/5 보강
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 📖 저널 OA 14.8% 2022: 0/2 OA 2023: 0/3 OA 2024: 4/7 OA 2025: 7/46 OA 2026: 31/223 OA 2022~2026 2025 Vol.27(2) p. 604-611
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 3/4)

유사 논문
P · Population 대상 환자/모집단
246 patients with GC.
I · Intervention 중재 / 시술
perioperative BT
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] Perioperative BT is related with poor prognosis in GC patients and miR-338-3p may be a prognostic biomarker for GC patients received perioperative BT. BT in perioperative GC patients should be cautious, especially for those with low levels of miR-338-3p.

Shi H, Feng Y, Yuan S, Chai J

📝 환자 설명용 한 줄

[BACKGROUND] Perioperative blood transfusion (BT) is frequent in the treatment of gastric cancer (GC), but its effects on the prognosis of GC remains controversial.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Shi H, Feng Y, et al. (2025). Association of miR-338-3p with survival outcomes in gastric cancer patients who received peri-operative blood transfusion.. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 27(2), 604-611. https://doi.org/10.1007/s12094-024-03628-9
MLA Shi H, et al.. "Association of miR-338-3p with survival outcomes in gastric cancer patients who received peri-operative blood transfusion.." Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 27, no. 2, 2025, pp. 604-611.
PMID 39097851 ↗

Abstract

[BACKGROUND] Perioperative blood transfusion (BT) is frequent in the treatment of gastric cancer (GC), but its effects on the prognosis of GC remains controversial. In this study, we aimed to further confirm the relationship of perioperative BT with GC overall survival and to evaluate the predictive value of microRNA-338-3p (miR-338-3p) for the prognosis of GC patients who received perioperative BT.

[METHODS] Clinical data and serum samples were collected and analyzed from 246 patients with GC. Five-year follow-up survival information was assessed by Kaplan-Meier survival analysis. miR-338-3p relative expression was assessed by RT-qPCR, and its relationship with the prognosis of GC patients, who received perioperative BT, was evaluated using Kaplan-Meier curves and Cox regression analysis.

[RESULTS] GC patients received perioperative BT had poor 5 year survival than those without BT. In patients received BT, miR-338-3p expression was higher in survival cases than died population and high miR-338-3p was independently associated with better overall survival prognosis.

[CONCLUSION] Perioperative BT is related with poor prognosis in GC patients and miR-338-3p may be a prognostic biomarker for GC patients received perioperative BT. BT in perioperative GC patients should be cautious, especially for those with low levels of miR-338-3p.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반